Trial intelligence / Profile preview

Acadesine in B-cell Chronic Lymphocytic Leukemia

NCT00559624Phase 2Completed

Sponsor
AdvanCell
Start
Dec 2007
Primary completion
Dec 2010
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of acadesine in chronic lymphocytic leukemia (CLL), sponsored by AdvanCell. Started Dec 2007; status: completed.

02

Drugs

acadesine
03

Conditions

chronic lymphocytic leukemia (CLL)

Beyond the preview

Go deeper on NCT00559624.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00559624.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call